Toxicological aspects for nanomaterial in humans.
暂无分享,去创建一个
Maria Dusinska | M. Dusinska | Z. Magdolénová | L. Fjellsbø | Zuzana Magdolenova | Lise Marie Fjellsbø
[1] Iseult Lynch,et al. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices , 2011, Nanotoxicology.
[2] Maria Dusinska,et al. Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. , 2010, The Science of the total environment.
[3] E. Zeiger,et al. Chromosome aberrations and sister chromatid exchanges in chinese hamster ovary cells: Evaluations of 108 chemicals , 1987, Environmental and molecular mutagenesis.
[4] Bengt Fadeel,et al. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. , 2011, Biochimica et biophysica acta.
[5] K. Audus,et al. Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. , 2002, International journal of pharmaceutics.
[6] Awadhesh N Jha,et al. Ecotoxicological applications and significance of the comet assay. , 2008, Mutagenesis.
[7] Lang Tran,et al. Risk management of nanomaterials. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[8] S. Maenosono,et al. Evaluation of genotoxicity of amine-terminated water-dispersible FePt nanoparticles in the Ames test and in vitro chromosomal aberration test. , 2009, The Journal of toxicological sciences.
[9] M. Hande,et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. , 2009, ACS nano.
[10] P. Mosesso,et al. Report from working group on in vitro tests for chromosomal aberrations. , 1994, Mutation research.
[11] B. Bay,et al. Current Studies into the Genotoxic Effects of Nanomaterials , 2010, Journal of nucleic acids.
[12] M. Fenech. Cytokinesis-block micronucleus cytome assay , 2007, Nature Protocols.
[13] Markus Schulz,et al. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. , 2009, Mutation research.
[14] Julie W. Fitzpatrick,et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.
[15] U. Wirnitzer,et al. Studies on the in vitro genotoxicity of baytubes, agglomerates of engineered multi-walled carbon-nanotubes (MWCNT). , 2009, Toxicology letters.
[16] D. Warheit,et al. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. , 2008, Pharmacology & therapeutics.
[17] K. Audus,et al. Permeability properties of monolayers of the human trophoblast cell line BeWo. , 1997, The American journal of physiology.
[18] P. M. Williams,et al. Confounding experimental considerations in nanogenotoxicology. , 2009, Mutagenesis.
[19] S. Doak,et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. , 2009, Biomaterials.
[20] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[21] Romualdo Benigni,et al. Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. , 2011, Mutagenesis.
[22] Maria Dusinska,et al. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles , 2014, Nanotoxicology.
[23] Lang Tran,et al. Nanoparticles, human health hazard and regulation , 2010, Journal of The Royal Society Interface.
[24] J. Howl,et al. Critical Evaluation of ECV304 as a Human Endothelial Cell Model Defined by Genetic Analysis and Functional Responses: A Comparison with the Human Bladder Cancer Derived Epithelial Cell Line T24/83 , 2000, Laboratory Investigation.
[25] Xing-Jie Liang,et al. Biopharmaceutics and therapeutic potential of engineered nanomaterials. , 2008, Current drug metabolism.
[26] Jinhee Choi,et al. p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. , 2010, Environmental science & technology.
[27] Vincent M Rotello,et al. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.
[28] A. D'emanuele,et al. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization. , 2009, Bioconjugate chemistry.
[29] Alexandra Kroll,et al. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] Peter Wipf,et al. Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.
[31] Christy L Haynes. The emerging field of nanotoxicology , 2010, Analytical and bioanalytical chemistry.
[32] Scott E McNeil,et al. Nanomaterial standards for efficacy and toxicity assessment. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[33] W. Chan,et al. Nanotoxicity: the growing need for in vivo study. , 2007, Current opinion in biotechnology.
[34] A. Collins,et al. Oxidative damage to DNA: do we have a reliable biomarker? , 1996, Environmental health perspectives.
[35] Gordon Chambers,et al. A new approach to the toxicity testing of carbon-based nanomaterials--the clonogenic assay. , 2007, Toxicology letters.
[36] A. Collins,et al. Detection of Oxidised Purines and UV-induced Photoproducts in DNA of Single Cells, by Inclusion of Lesion-specific Enzymes in the Comet Assay , 1996 .
[37] M. Kirsch‐Volders,et al. Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. , 2011, Mutagenesis.
[38] Margaret Saunders,et al. Transplacental transport of nanomaterials. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[39] Maria Dusinska,et al. Testing strategies for the safety of nanoparticles used in medical applications. , 2009, Nanomedicine.
[40] Myrtill Simkó,et al. Risks from accidental exposures to engineered nanoparticles and neurological health effects: A critical review , 2010, Particle and Fibre Toxicology.
[41] H. Byrne,et al. Investigation of Sodium Dodecyl Benzene Sulfonate Assisted Dispersion and Debundling of Single-Wall Carbon Nanotubes , 2008 .
[42] Shinobu Ito,et al. Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. , 2006, Toxicology.
[43] M. Fenech,et al. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. , 2011, Mutagenesis.
[44] E. Zeiger,et al. The Ames Salmonella/microsome mutagenicity assay. , 2000, Mutation research.
[45] Bengt Fadeel,et al. Nanotoxicology: no small matter. , 2010, Nanoscale.
[46] Martin J. D. Clift,et al. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative , 2010, Archives of Toxicology.
[47] Stefano Bellucci,et al. Multi-walled carbon nanotubes: Lack of mutagenic activity in the bacterial reverse mutation assay. , 2009, Toxicology letters.
[48] N. K. Jain,et al. Pulmonary toxicity of carbon nanotubes: a systematic report. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[49] André Nel,et al. ATMOSPHERE: Enhanced: Air Pollution-Related Illness: Effects of Particles , 2005 .
[50] Rudolf Hagen,et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. , 2011, Toxicology letters.
[51] Shigehisa Endoh,et al. In vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles. , 2009, Toxicology letters.
[52] W. Seeger,et al. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. , 2006, Toxicology and applied pharmacology.
[53] P. Borm,et al. Nanoparticles in drug delivery and environmental exposure: same size, same risks? , 2006, Nanomedicine.
[54] Tung-Sheng Shih,et al. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. , 2008, Toxicology letters.
[55] S. Maenosono,et al. Mutagenicity of water-soluble ZnO nanoparticles in Ames test. , 2007, The Journal of toxicological sciences.
[56] Dana Loomis,et al. Work in Brief , 2006 .
[57] Helinor Johnston,et al. Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.
[58] S. Hussain,et al. In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella/microsome assay. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.
[59] A. Abbott. Cell culture: Biology's new dimension , 2003, Nature.
[60] Alok Dhawan,et al. Toxicity assessment of nanomaterials: methods and challenges , 2010, Analytical and bioanalytical chemistry.
[61] A. Humpage,et al. Flow-cytometric analysis of in vitro micronucleus formation: comparative studies with WIL2-NS human lymphoblastoid and L5178Y mouse lymphoma cell lines. , 2008, Mutation research.
[62] Andrew D Maynard,et al. The new toxicology of sophisticated materials: nanotoxicology and beyond. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.